首页|右美托咪定复合依托咪酯靶控输注用于老年患者内窥镜逆行胆管造影术的麻醉效果探讨

右美托咪定复合依托咪酯靶控输注用于老年患者内窥镜逆行胆管造影术的麻醉效果探讨

扫码查看
目的 探讨分析右美托咪定复合依托咪酯在脑卒中介入治疗麻醉中的应用价值.方法 选取2021年7月—2023年7月在本院就诊的脑卒中介入治疗麻醉患者80例为研究对象,按照时间先后顺序分为对照组和观察组,每组40例.其中,对照组采用依托咪酯麻醉,观察组采用右美托咪定复合依托咪酯麻醉,对比分析两组患者术后自主呼吸恢复时间、气管拔管时间和清醒时间、不同时间点MAP和HR、治疗后APACHEⅡ评分与GCS评分情况以及不良反应发生情况.结果 观察组患者术后自主呼吸恢复时间、气管拔管时间和清醒时间与对照组相比,观察组明显更低(P<0.05);观察组患者T1~T4时MAP和HR与对照组相比,观察组明显更低(P<0.05).两组T0相比,差异无统计学意义(P>0.05);观察组治疗后APACHEⅡ评分与GCS评分情况与对照组相比,观察组明显更好(P<0.05);观察组不良反应发生率达低于对照组(P<0.05).结论 在脑卒中患者的介入性治疗过程中,采用右美托咪定联合依托咪酯的用药策略,其应用价值尤为突出.此方案能够显著降低患者的不良反应发生率,有效维护患者的呼吸与循环功能的稳定,同时展现出极高的安全性和有效性.
Anesthesia Effect Exploration of Dexmedetomidine Combined with Etomidate Target Controlled Infusion for Endoscopic Retrograde Cholangiography of Elderly Patients
Objective To explore and analyze application value of dexmedetomidine combined with etomidate in the interventional treatment of stroke anesthesia. Methods This hospital 80 stroke patients in our hospital for interventional treatment and anesthesia from July 2021 to July 2023 into two groups according to sequence,the control group and the observation group,with 40 cases in each group,treated with etomidate anesthesia,dexmedetomidine combined with etomidate respectively. The postoperative spontaneous breathing recovery time,tracheal extubation time and wakefulness time,MAP and HR at different time points,APACHE Ⅱ scores and GCS scores after treatment,and incidence of adverse reactions were used as evaluation indicators of two groups. Results Postoperative spontaneous breathing recovery time,tracheal extubation time,and wakefulness time in the observation group was significantly shorter than the control group,difference was significant (P<0.05). The MAP and HR from T1 to T4 in the observation group were significantly lower than the control group,with statistical difference. There was no significant difference between two groups compared with compared with T0,P>0.05. After treatment,the APACHE Ⅱ scores and GCS scores in the observation group were significantly better than the control group,with significant difference (P<0.05). Incidence of adverse reactions in the observation group was 7.50% (3/40),lower than 32.50% (13/40) in the control group,with statistical difference,P<0.05. Conclusion Dexmedetomidine combined with etomidate can achieve significant application value in stroke intervention surgery,can control the adverse reactions,maintain breathing and circulation of patients effectively,which has significant safety and effectiveness.

StrokeDexmedetomidineEtomidateAnaesthesia

朱延海、张曙

展开 >

上海市中西医结合医院麻醉科,上海 200082

卒中 右美托咪啶 依托咪酯 麻醉

2024

智慧健康

智慧健康

ISSN:
年,卷(期):2024.10(27)